Search Results

Tumor-Associated Macrophage (TAM)-Related Cytokines, sCD163, CCL2, and CCL4, as Novel Biomarkers for Overall Survival and Time to Treatment in Waldenstrom's Macroglobulinemia: Emphasis on Asymptomatic WM.

• Authors : Gkiokas A; Hematology Section, First Department of Propaedeutic Internal Medicine, Laikon Hospital, Faculty of Medicine, National and Kapodistrian University of Athens, 11527 Athens, Greece.; Papadatou-Gigante M

Subjects: Antigens, Differentiation, Myelomonocytic*/Antigens, Differentiation, Myelomonocytic*/Antigens, Differentiation, Myelomonocytic*/blood ; Antigens, Differentiation, Myelomonocytic*/Antigens, Differentiation, Myelomonocytic*/Antigens, Differentiation, Myelomonocytic*/metabolism ; Antigens, CD*/Antigens, CD*/Antigens, CD*/metabolism

• Source: Cells [Cells] 2025 Feb 13; Vol. 14 (4). Date of Electronic Publication: 2025 Feb 13.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101600052 Publication Model: Electronic Cited Medium: Internet ISSN: 2073-4409

Record details

Conditional deletion of Ccl2 in smooth muscle cells does not reduce early atherosclerosis in mice

• Authors : Gunnersen, S; Shim, JT; Liu, F

Subjects: Medicin och hälsovetenskap

• Source: Atherosclerosis plus. 55:12-20

Record details

Chemokine CCL2 and its receptor CCR2 in different age groups of patients with COVID-19.

• Authors : Bagheri V; Immunology of Infectious Diseases Research Center, Research Institute of Basic Medical Sciences, Rafsanjan University of Medical Sciences, Rafsanjan, Iran.; Khorramdelazad H

Subjects: Receptors, CCR2*/Receptors, CCR2*/Receptors, CCR2*/metabolism ; Receptors, CCR2*/Receptors, CCR2*/Receptors, CCR2*/genetics ; COVID-19*/COVID-19*/COVID-19*/immunology

• Source: BMC immunology [BMC Immunol] 2024 Oct 26; Vol. 25 (1), pp. 72. Date of Electronic Publication: 2024 Oct 26.Publisher: BioMed Central Country of Publication: England NLM ID: 100966980 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2172

Record details

Noninvasive prediction of CCL2 expression level in high-grade glioma patients.

• Authors : Zhou Q; Department of Neurosurgery, The First Affiliated Hospital of Yangtze University, Jingzhou First People's Hospital, Jingzhou, People's Republic of China.; Wang Y

Subjects: Brain Neoplasms*/Brain Neoplasms*/Brain Neoplasms*/diagnostic imaging ; Brain Neoplasms*/Brain Neoplasms*/Brain Neoplasms*/genetics ; Brain Neoplasms*/Brain Neoplasms*/Brain Neoplasms*/metabolism

• Source: Cancer medicine [Cancer Med] 2024 Jul; Vol. 13 (14), pp. e70016.Publisher: John Wiley & Sons Ltd Country of Publication: United States NLM ID: 101595310 Publication Model: Print Cited Medium: Internet ISSN:

Record details

SUMO modified ETV1 promotes M2-polarized tumor-associated macrophage infiltration and cancer progression by facilitating CCL2 transcription in esophageal squamous cell carcinoma cells

• Authors : Tianci Han; Xiaoqi Guo; Junwei Xie

Subjects: Esophageal squamous cell carcinoma; Tumor-associated macrophages; ETV1

• Source: Cancer Immunology, Immunotherapy, Vol 74, Iss 3, Pp 1-17 (2025)

Record details

血清 CCL2、CCL5、CXCL10 与腰椎间盘突出症患者术后 早期疼痛缓解的关系研究.

• Authors : 王守康¹ ; 梁 刚¹; 刘晓磊¹

• Source: Progress in Modern Biomedicine. Oct2024, Vol. 24 Issue 19, p3692-3695. 4p.

Record details

M2-like tumor-associated macrophage-secreted CCL2 facilitates gallbladder cancer stemness and metastasis.

• Authors : Chen, Weihong^1,2,3,4 (AUTHOR); Chen, Mingyuan^1,2 (AUTHOR); Hong, Lingju¹ (AUTHOR)

• Source: Experimental Hematology & Oncology. 8/13/2024, Vol. 13 Issue 1, p1-19. 19p.

Record details

Assessment of urine CCL2 as a potential diagnostic biomarker for acute kidney injury and septic acute kidney injury in intensive care unit patients.

• Authors : Peng Y; Intensive Care Unit, The First People's Hospital of Kunshan Affiliated to Jiangsu University, Kunshan, PR China.; Wang Q

Subjects: Sepsis*/Sepsis*/Sepsis*/diagnosis ; Sepsis*/Sepsis*/Sepsis*/complications ; Acute Kidney Injury*

• Source: Renal failure [Ren Fail] 2024 Dec; Vol. 46 (1), pp. 2313171. Date of Electronic Publication: 2024 Feb 12.Publisher: Informa Healthcare Country of Publication: England NLM ID: 8701128 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

CCL2 promotes EGFR-TKIs resistance in non-small cell lung cancer via the AKT-EMT pathway

• Authors : Diao Yunlian; Huang Shibo; Liu Fangpeng

Subjects: EGFR-TKIs resistance; non-small cell lung cancer; CCL2

• Source: Acta Biochimica et Biophysica Sinica, Vol 56, Pp 1549-1560 (2024)

Record details

hs-CRP、CCL2、CCL3 与新生儿细菌感染病情关系及疗效预测价值.

• Authors : 袁振兴¹; 孙文菲¹; 王卫东¹

• Source: Journal of Kunming Medical University / Kunming Yike Daxue Xuebao. 2024, Issue 7, p119-125. 7p.

Record details